Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Endocrinology
•
Pituitary Disorders
Can combined oral contraceptive use cause falsely elevated 24-hour urine-free cortisol?
Answer from: at Community Practice
UFC is an expression of free cortisol. It should not be affected by oral estrogen.
Sign in or Register to read more
Answer from: at Community Practice
Cushing is generally diagnosed by multiple tests so if one is abnormal, it is recommended to do other tests such as an overnight dexamethasone suppression test and saliva cortisol and put everything together to make the diagnosis.
Sign in or Register to read more
20091
20071
Related Questions
When and how do you taper off cabergoline therapy for treatment of microprolactinoma?
Do you recommend increased screening for hypercortisolism in older patients given recent evidence that older patients do not commonly display hallmark symptoms of Cushing's Disease?
Should we be aiming for normalization of both late-night salivary cortisol and 24hr urinary free cortisol levels when monitoring response to Cushing's disease treatment?
What is the likelihood of recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients who develop immunotherapy induced adrenal insufficiency?
What specific clinical factors would drive you to recommend surgical intervention for patients with small, nonfunctional pituitary adenomas who exhibit no neurological symptoms?
Should we be considering transsphenoidal surgical resection as first-line therapy for prolactinomas?
Do you interpret failure to develop hypernatremia with prolonged water deprivation (such as for 12 hours) as evidence against diabetes insipidus even if the urine osmolality is just below normal?
Does growth hormone (GH) replacement therapy reduce the risk of fractures in patients with GH deficiency?
What is your approach to managing patients with new laboratory evidence of hypopituitarism (e.g. very low plasma ACTH level and low morning serum cortisol) and a remote history of trans-sphenoidal surgery for NFPA?
How do you approach monitoring for autoimmune disorders in patients with surgical remission of Cushing’s disease, given the higher incidence of autoimmune disease in this population?